1. Nemeroff CB. The burden of severe depression: a review of diagnostic challenges and treatment alternatives. J Psychiatr Res 2007; 41:189-206.
2. Neal MJ. Medical pharmacology at a Glance. 7th ed. John Wiley & Sons; 2012.
3. Howland RD, Mycek MJ, Harvey RA, Champe PC. Lippincott's illustrated reviews: Pharmacology 5th ed. Lippincott Williams & Wilkins; 2006.
4. Meyers S. Monoaminergic supplements as natural antidepressants. Altern Med Rev 2000; 5:64-71.
5. Hasler G. Pathophysiology of depression: do we have any solid evidence of interest to clinicians? World Psychiatr 2010; 9:155-161.
6. Papakostas GI. Dopaminergic-based pharmacotherapies for depression. Eur Neuropsychopharmacol 2006; 16:391-402.
7. Trevor AJ, Katzung BG, Masters SB, Kruidering-Hall M. Pharmacology Examination & Board Review. 11th ed. McGraw-Hill Medical; 2010.
8. Tamminga CA, Nemeroff CB, Blakely RD, Brady L, Carter CS, Davis KL, et al. Developing novel treatments for mood disorders: accelerating discovery. Biol Psychiatry 2002; 52:589-609.
9. Zhang ZJ. Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders. Life Sci 2004; 75:1659-1699.
10. Asgary S, Rahimi P, Mahzouni P, Madani H. Antidiabetic effect of hydroalcoholic extract of Carthamus tinctorius L. in alloxan-induced diabetic rats. J Res Med Sci 2012; 17:386.
11. Zargari A. Medicinal plants. 8th ed. Tehran University Press; 2014.
12. Abbasi Maleki S. Effect of ethanolic extract of Safflower on naloxone-induced morphine withdrawal signs in mice. Adv Herb Med 2015; 1:9-15.
13. Zhao G, Gai Y, Chu WJ, Qin GW, Guo LH. A novel compound N 1, N 5-(Z)-N 10-(E)-tri-p-coumaroylspermidine isolated from Carthamus tinctorius L. and acting by serotonin transporter inhibition. Eur Neuropsychopharmacol 2009; 19:749-758.
14. Zhao G, Zheng XW, Gai Y, Chu WJ, Qin GW, Guo LH. Safflower extracts functionally regulate monoamine transporters. J Ethnopharmacol 2009; 124:116-124.
15. Al Hashmi LS, Hossain MA, Weli AM, Al-Riyami Q, AlSabahi JN. Gas chromatography–mass spectrometry analysis of different organic crude extracts from the local medicinal plant of Thymus vulgaris L. Asian Pac J Trop Biomed 2013; 3:69-73.
16. Lorke D. A new approach to practical acute toxicity. Arch Toxicol 1983; 53:275-289.
17. OECD/OCDE 423. OECD web. Consulted 22 May 2009. http://iccvam.niehs.nih.gov/SuppDocs/FedDocs/OECD/OECD GL423.pdf.
18. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacol 1985; 85:367-370.
19. Jesse CR, Wilhelm EA, Bortolatto CF, Nogueira CW. Evidence for the involvement of the noradrenergic system, dopaminergic and imidazoline receptors in the antidepressant-like effect of tramadol in mice. Pharmacol Biochem Behav 2010; 95:344-350.
20. Voiculescu SE, Rosca AE, Zeca V, Zagrean L, Zagrean AM. Impact of maternal melatonin suppression on forced swim and tail suspension behavioral despair tests in adult offspring. J Med Life 2015; 8:202-206.
21. Piotrowska A, Siwek A, Wolak M, Pochwat B, Szewczyk B, Opoka W, et al. Involvement of the monoaminergic system in the antidepressant-like activity of chromium chloride in the forced swim test. J Physiol Pharmacol 2013; 64:493-498.
22. Przegaliński E, Moryl E, Papp M. The effect of 5-HT 1A receptor ligands in a chronic mild stress model of depression. Neuropharmacol 1995; 34:1305-1310.
23. Tanyeri P, Buyukokuroglu ME, Mutlu O, Ulak G, Akar FY, Celikyurt IK, et al. Involvement of serotonin receptor subtypes in the antidepressant-like effect of beta receptor agonist Amibegron (SR 58611A): an experimental study. Pharmacol Biochemy Behav 2013; 105:12-16.
24. Gu L, Liu YJ, Wang YB, Yi LT. Role for monoaminergic systems in the antidepressant-like effect of ethanol extracts from Hemerocallis citrina. J Ethnopharmacol 2012; 139:780-787.
25. Binfaré RW, Rosa AO, Lobato KR, Santos AR, Rodrigues AL. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog Neuropsychopharmacol Biol Psychiatry 2009 ;30:530-540.
26. Harkin A, Connor T, Walsh M, St John N, Kelly J. Serotonergic mediation of the antidepressant-like effects of nitric oxide synthase inhibitors. Neuropharmacol 2003; 44:616-623.
27. Zheng M, Li Y, Shi D, Liu C, Zhao J. Antidepressant-like effects of flavonoids extracted from Apocynum venetum leaves in mice: the involvement of monoaminergic system in mice. Afr J Pharm Pharmacol 2014; 8:765-774.
28. Ishola IO, Agbaje EO, Akinleye MO, Ibeh CO, Adeyemi OO. Antidepressant-like effect of the hydroethanolic leaf extract of Alchornea cordifolia (Schumach. & Thonn.) Mull Arg(Euphorbiaceae) in mice: Involvement of monoaminergic system. J Ethnopharmacol 2014; 158:364-372.
29. Brown RE, Corey SC. Moore AK. Differences in Measures of Exploration and Fear in MHC-Congenic C57BL/6J and B6-H-2K Mice. Behav Genet 1999; 29:263.
30. Borsini F, Lecci A, Mancinelli A, D'Aranno V, Meli A. Stimulation of dopamine D-2 but not D-1 receptors reduces immobility time of rats in the forced swimming test: implication for antidepressant activity. Eur J Pharmacol 1988; 148:301-307.
31. Jafarpoor N, Abbasi-Maleki S, Asadi-Samani M, Khayatnouri MH. Evaluation of antidepressant- like effect of hydroalcoholic extract of Passiflora incarnata in animal models of depression in male mice. J Herb Med Pharmacol 2014 ; 3:41- 45.
32. Moallem SA, Hosseinzadeh H, Ghoncheh F. Evaluation of antidepressant effects of aerial parts of echium vulgare on mice . Iran J Basic Med Sci 2007; 10:189-196.
33. Shahamat Z, Abbasi-Maleki S, Mohammadi Motamed S. Evaluation of antidepressant-like effects of aqueous and ethanolic extracts of Pimpinella anisum fruit in mice. Avicenna J Phytomed 2016; 6:322-328.
34. Jia LH, Liu Y, Li YZ. Rapid determination of volatile constituents in safflower from Xinjiang and Henan by ultrasonic-assisted solvent extraction and GC–MS. J Pharm Anal 2011; 1: 213–218.
35. Bazinet RP, Laye S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 2014; 15:771–785.
36. Henry GE, Momin RA, Nair MG, Dewitt DL. Antioxidant and cyclooxygenase activities of fatty acids found in food. J Agric Food Chem 2002; 50:2231-2234.
37. Elagbar ZA, Naik RR, Shakya AK, Bardaweel SK. Fatty ascids analysis, antioxidant and biological activity of fixed oil of annona muricata L. Seeds. J Chem 2016;2016: 1-6.
38. Yoshida Y, Niki E. Antioxidant effects of phytosterol and its components. J Nutr Sci Vitaminol (Tokyo) 2003; 49:277-280.
39. Scapagnini G, Davinelli S, Drago F, De Lorenzo A, Oriani G. Antioxidants as antidepressants: fact or fiction?. CNS Drugs 2012; 26:477-490.
40. Slamon ND, Pentreath VW. Antioxidant defense against antidepressants in C6 and 1321N1 cells.Chem Biol Interact 2000; 127:181-199.
41. Kolla N, Wei Z, Richardson JS, Li XM. Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide. J Psychiatry Neurosci 2005; 30:196–201.
42. Elhwuegi AS. Central monoamines and their role in major depression. Prog Neuro-Psychopharmacol Biol Psychiatr 2004; 28:435-451.
43. Risch SC, Nemeroff CB. Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry. J Clin Psychiatry 1992; 53:3-7.
44. Willner P, Hale AS, Argyropoulos S. Dopaminergic mechanism of antidepressant action in depressed patients. J Affect Disord 2005; 86:37-45.
45. Hirano S, Miyata S, Onodera K, Kamei J. Involvement of dopamine D 1 receptors and α 1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test. Eur J Pharmacol 2007; 562:72-76.
46. Machado DG, Kaster MP, Binfaré RW, Dias M, Santos AR, Pizzolatti MG, et al. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Prog Neuro-Psychopharmacol Biol Psychiatr 2007; 31:421-428.
47. Wæhrens J, Gerlach J. Bromocriptine and imipramine in endogenous depression: a double-blind controlled trial in out-patients. J Affect Disord 1981; 3:193-202.
48. Marien MR, Colpaert FC, Rosenquist AC. Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 2004; 45:38-78.
49. Haider S, Khaliq S, Haleem DJ. Enhanced serotonergic neurotransmission in the hippocampus following tryptophan administration improves learning acquisition and memory consolidation in rats. Pharmacol Rep 2007; 59:53.
50. Celada P, Puig MV, Amargós-Bosch M, Adell A, Artigas F. The therapeutic role of 5-HT 1A and 5-HT 2A receptors in depression. Psychiatry Neurosci 2004; 29:252.
51. Shrestha S, Hirvonen J, Hines CS, Henter ID, Svenningsson P, Pike VW, et al. Serotonin-1A receptors in major depression quantified using PET: controversies, confounds, and recommendations. Neuroimage 2012; 59:3243-3251.
52. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34:13-25.
53. Machado DG, Bettio LE, Cunha MP, Capra JC, Dalmarco JB, Pizzolatti MG, et al. Antidepressant-like effect of the extract of Rosmarinus officinalis in mice: involvement of the monoaminergic system. Prog Neuro-Psychopharmacol Biol Psychiatr 2009; 33:642-650.
54. Kuehnl S, Schroecksnadel S, Temml V, Gostner JM, Schennach H, Schuster D, et al. Lignans from Carthamus tinctorius suppress tryptophan breakdown via indoleamine 2, 3-dioxygenase. Phytomed 2013; 20:1190-1195.
55. Frazer A. Norepinephrine involvement in antidepressant action. J Clin Psychiatry 2000; 61:25-30.
56. Nutt DJ, Baldwin DS, Clayton AH. The role of dopamine and norepinephrine in depression and antidepressant treatment. J Clin Psychiatry 2006; 67:3-8.
57. Sarris J, Kavanagh DJ, Byrne G. Adjuvant use of nutritional and herbal medicines with antidepressants, mood stabilizers and benzodiazepines. J Psychiatr Res 2010; 44:32-41.
58. Lam RW, Wan DD, Cohen NL, Kennedy SH. Combining antidepressants for treatment resistant depression: a review. J Clin Psychiatry 2002; 63:685-693.